Skip Navigation


Human Molecular Genetics Advance Access originally published online on January 13, 2005
Human Molecular Genetics 2005 14(5):603-614; doi:10.1093/hmg/ddi057
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
14/5/603    most recent
ddi057v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rebouissou, S.
Right arrow Articles by Zucman-Rossi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rebouissou, S.
Right arrow Articles by Zucman-Rossi, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol. 14, No. 5 © Oxford University Press 2005; all rights reserved

Germline hepatocyte nuclear factor 1{alpha} and 1ß mutations in renal cell carcinomas

Sandra Rebouissou1, Viorel Vasiliu2, Cristel Thomas1, Christine Bellanné-Chantelot5, Hung Bui6, Yves Chrétien3, José Timsit7, Christophe Rosty8, Pierre Laurent-Puig9, Dominique Chauveau4 and Jessica Zucman-Rossi1,*

1Inserm U674, CEPH, IUH Saint-Louis, Paris, France, 2Service d'Anatomopathologie, 3Service d'Urologie and 4Service de Néphrologie et Inserm U507, Hôpital Necker, AP-HP, Paris France, 5Laboratoire de Génétique et Biologie Moléculaire, Hôpital Saint-Antoine, AP-HP, Paris, France, 6CEPH, Fondation Jean Dausset, Paris, France, 7Service d'Endocrinologie, Hôpital Cochin, AP-HP, Paris, France, 8Service de pathologie, Institut Curie, Paris, France and 9Inserm U490, Paris, France

* To whom correspondence should be addressed at: Inserm U434, CEPH, IUH Paris Saint-Louis, 27 rue Juliette Dodu, 75010 Paris, France. Tel: +33 153725166; Email: zucman{at}cephb.fr

Received September 29, 2004; Revised December 14, 2004; Accepted January 5, 2005

Mutations in one copy of the hepatocyte nuclear factors (HNF) 1{alpha} and 1ß homeodomain containing transcription factors predispose the carrier to maturity-onset diabetes of the young (MODY) types 3 and 5, respectively. Moreover, previous identification of biallelic inactivation of HNF1{alpha} in hepatocellular adenoma identified its tumor suppressor function in hepatocarcinogenesis. The seminal observation of an ovarian carcinoma in a MODY5 patient who subsequently developed a chromophobe renal cell carcinoma, prompted us to screen for HNF1ß and HNF1{alpha} inactivation in a series of 20 ovarian and 35 renal neoplasms. Biallelic HNF1ß inactivation was found in two of 12 chromophobe renal carcinomas by association of a germline mutation and a somatic gene deletion. In these cases, the expression of PKHD1 (polycystic kidney and hepatic disease 1) and UMOD (Uromodulin), two genes regulated by HNF1ß, was turned off. Interestingly, in two of 13 clear cell renal carcinomas, we found a monoallelic germline mutation of HNF1{alpha} with no associated suppression of target mRNA expression. In normal and tumor renal tissues, we showed the existence of a network of transcription factors differentially regulated in tumor subtypes. We identified two related clusters of co-regulated genes associating HNF1ß, PKHD1 and UMOD in the first group and HNF1{alpha}, HNF4{alpha}, FABP1 and UGT2B7 in the second group. Finally, these results suggest that germline mutations of HNF1ß and HNF1{alpha} may predispose to renal tumors. Furthermore, we suggest that HNF1ß functions as a tumor suppressor gene in chromophobe renal cell carcinogenesis through a PKHD1 expression control.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
X. Song, V. Di Giovanni, N. He, K. Wang, A. Ingram, N. D. Rosenblum, and Y. Pei
Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks
Hum. Mol. Genet., July 1, 2009; 18(13): 2328 - 2343.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Adalat, A. S. Woolf, K. A. Johnstone, A. Wirsing, L. W. Harries, D. A. Long, R. C. Hennekam, S. E. Ledermann, L. Rees, W. van't Hoff, et al.
HNF1B Mutations Associate with Hypomagnesemia and Renal Magnesium Wasting
J. Am. Soc. Nephrol., May 1, 2009; 20(5): 1123 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Rebouissou, S. Imbeaud, C. Balabaud, V. Boulanger, J. Bertrand-Michel, F. Terce, C. Auffray, P. Bioulac-Sage, and J. Zucman-Rossi
HNF1{alpha} Inactivation Promotes Lipogenesis in Human Hepatocellular Adenoma Independently of SREBP-1 and Carbohydrate-response Element-binding Protein (ChREBP) Activation
J. Biol. Chem., May 11, 2007; 282(19): 14437 - 14446.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Eller, S. Kaser, K. Lhotta, E. L. Edghill, S. Ellard, C. Ebenbichler, and J. R. Patsch
Renal cysts and diabetes due to a heterozygous HNF-1{beta} gene deletion
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1271 - 1272.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Decramer, O. Parant, S. Beaufils, S. Clauin, C. Guillou, S. Kessler, J. Aziza, F. Bandin, J. P. Schanstra, and C. Bellanne-Chantelot
Anomalies of the TCF2 Gene Are the Main Cause of Fetal Bilateral Hyperechogenic Kidneys
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 923 - 933.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Bellanne-Chantelot, S. Clauin, D. Chauveau, P. Collin, M. Daumont, C. Douillard, D. Dubois-Laforgue, L. Dusselier, J.-F. Gautier, M. Jadoul, et al.
Large Genomic Rearrangements in the Hepatocyte Nuclear Factor-1{beta} (TCF2) Gene Are the Most Frequent Cause of Maturity-Onset Diabetes of the Young Type 5
Diabetes, November 1, 2005; 54(11): 3126 - 3132.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.